NASDAQ · Analyst Forecast

Bolt Biotherapeutics, Inc. (BOLT) Stock Forecast & Price Target

$5.65 NASDAQ: BOLT Market Cap $10.88M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Bolt Biotherapeutics, Inc. (BOLT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Bolt Biotherapeutics, Inc., analysts forecast revenue rising from $5.87M in 2025 to $8.00M in 2030; the average estimate for 2030 earnings per share is −$40.09; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$5.65
Consensus targetThe average of the price targets analysts have published.$4.00
Median targetThe middle target, less affected by a single outlier.$4.00
Highest targetThe most optimistic published target.$7.00
Lowest targetThe most pessimistic published target.$1.00
Difference from priceHow far the consensus target sits from today’s price.-29.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$5.39M$5.87M$6.34M3
2026$133,333$133,333$133,3331
2027$3.50M$3.50M$3.50M2
2028$8.00M$8.00M$8.00M1
2029$8.00M$8.00M$8.00M1
2030$8.00M$8.00M$8.00M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$22.10−$21.23−$20.353
2026−$18.27−$18.27−$18.271
2027−$24.74−$20.19−$15.642
2028−$30.84−$30.84−$30.841
2029−$35.53−$35.53−$35.531
2030−$40.09−$40.09−$40.091

Bolt Biotherapeutics, Inc. (BOLT) forecast — frequently asked questions

What is the analyst price target for Bolt Biotherapeutics, Inc.?

Analysts covering Bolt Biotherapeutics, Inc. (BOLT) have a consensus price target of $4.00, 29.2% below the current price of $5.65. Published targets range from $1.00 to $7.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Bolt Biotherapeutics, Inc.'s earnings?

The average analyst estimate for Bolt Biotherapeutics, Inc. (BOLT) earnings per share in 2030 is -40.09, with individual estimates between -40.09 and -40.09.

How much revenue is Bolt Biotherapeutics, Inc. expected to make?

Analysts forecast Bolt Biotherapeutics, Inc. (BOLT) revenue of $8.00M in 2030, based on 1 published estimates.

How many analysts cover BOLT?

3 analysts contribute estimates for Bolt Biotherapeutics, Inc. (BOLT). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.